-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Pulse Biosciences, Raises Price Target to $64

Benzinga·11/06/2026 12:24:28
Listen to the news
Needham analyst Mike Matson maintains Pulse Biosciences (NASDAQ:PLSE) with a Buy and raises the price target from $58 to $64.